Global Antimania Drugs Market Drivers
The global antimania drugs market is expected to witness significant growth over the forecast period, owing to growing prevalence of bipolar disorder, globally. For instance, according to the World Health Organization (WHO) 2019 report, around 45 million people get affected by bipolar disorder globally.
Moreover, cost effectiveness of drugs for the treatment of bipolar disorder is another factor that is expected to drive the global antimania drugs market growth over the forecast period. For instance, cost of olanzapine is US$ 153, while cost of lithium is US$ 16 per month.
Furthermore, increasing number of clinical trials of drug for the treatment of bipolar depression, which is expected to propel the global antimania drugs market growth over the forecast period. For instance, in July 2018, Lumateperone received positive results from the Phase 3 clinical trial (Study 401 and Study 404) for the treatment of bipolar depression, announced by Intra-Cellular Therapies, Inc. In both the trials (Study 401 and Study 404), Lumateperone was found safer and tolerable by patients.
Moreover, in October 2019, Psychiatry Consortium, which is a strategic collaboration of leading medical research charities and pharmaceutical companies to accelerate innovative drug discovery in psychiatric diseases, had announced to launch a novel drug project to address people with mental health conditions such as bipolar disorder, depression and other mental disorders.
Psychiatry Consortium is a pioneering collaboration between the pharmaceutical companies, healthcare companies as well as leading medical charities. Therefore, increasing initiatives by companies to support the novel drug project, which in turn, is expected to increase the launch of new drugs for treatment of patients with mental health condition such as bipolar disorder and hence drives the global antimania drugs market growth.
Global Antimania Drugs Market Restraints
However, side effects associated with lithium for the treatment of bipolar disorder is one of the major factors that is expected to restrain the global antimania drugs market growth over the forecast period. For instance, if patient takes overdose of lithium, it causes anorexia. Moreover, prolong use of lithium can damage body’s ability to respond properly to the hormone vasopressin and can result into diabetes insipidus.
Antimania Drugs Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients